Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

Medytox

Status: Completed

Conditions: Overweight

Treatments: Dietary Supplement: Placebo; Dietary Supplement: LMT1-48

Study type: Interventional

Funder types: Industry

Identifiers

NCT03759743

MT13-KR17OWT712

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects

Enrollment: 97 patients

Sex: All

Ages: 19 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age between 19 and 70 years
• Overweight (25 kg/m2 ≤ body mass index (BMI) < 30 kg/m2)

Exclusion criteria

• Pregnancy or breast-feeding
• Unstable body weight (body weight change > 10% within 3 months before screening)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

97 participants in 2 patient groups, including a placebo group

Probiotics

Experimental group

Treatment:

Dietary Supplement: LMT1-48

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo